Stage (next event)
Catalyst Info & Data Links
TITLE: VBI-2601 for Hepatitis B Virus (HBV) - Phase 1B/2A (Data)
WHAT IS THE NEXT CATALYST EVENT?
Phase 1B/2A (Data)
WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?
Q4 2020 (see slide 4)
Mechanism of Action
MECHANISM OF ACTION / RATIONALE
VBI believes VBI-2601 has the unique potential to do this by targeting B- and T-cell immunity through several key mechanisms of action, including neutralizing circulation of the hepatitis B virus, blocking infection of hepatocytes via Pre-S1 immunity, and enabling immune-mediated clearance of HBV-infected hepatocytes (Learn more HERE).
Updated by HC
Prior Data (click to view full image)
Trial Design / Revenue (click to view full image)
See what the community is saying - click to see full post